PT Kalbe Farma Tbk
PTKFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.81B
Close$
$0.12
212.3% upside
Current Fair Value
212.3% upsideUndervalued by 212.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.81 Billion |
|---|---|
| Enterprise Value | $-5,126,323,885,200.00 |
| Annual dividend | $0.00 |
| Dividend yield | 2.63% |
| Earnings per Share | $80.51 |
| Beta | -0.19 |
| Outstanding Shares | 45,202,870,000 |
Return
| Return on Equity | 15.05% |
|---|---|
| Return on Assets | 11.32% |
| Return on Invested Capital | 17.36% |
Valuation & Multiples
| P/E Ratio | 9.13 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | 6.18 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.00
Consensus analyst estimateRevenue Estimate
$557.95 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
$0.00
Consensus analyst estimateRevenue Estimate
$545.45 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PT Kalbe Farma Tbk
12,806 employees
CEO: Vidjongtius
PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. T...